To qualify for semaglutide, youll typically need to meet specific criteria: either a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
Hamdar H (2025)
Furthermore, the impact of GLP-1 mimetics to inhibit appetite and reduce body weight should also be considered when interpreting effects of these drug on bone turnover in humans
Oral glutathione tablets deliver the antioxidant through your digestive system
Moderate interaction risk may exist with chemotherapy medicines, because antioxidants may affect how some cancer treatments work
Summary: Retatrutide should not be combined with insulin or sulfonylureas without medical supervision, and caution is advised with anticoagulants, narrow therapeutic index drugs, other GLP-1 receptor agonists, and supplements with hypoglycaemic properties